Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Effect of topical anti-glaucoma medications on late pupillary light reflex, as evaluated by pupillometry

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Editorial: Impact of Traumatic Brain Injuries on Participation in Daily Life and Work: Recent Research and Future Directions

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Measuring Neurobehavioral Disabilities Among Severe Brain Injury Survivors: Reports of Survivors and Proxies in the Chronic Phase

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Effect of Intermittent versus Continuous Light Exposure on Pupillary Light Response, As Evaluated by Pupillometry

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Melanopsin-mediated pupillary light reflex and sleep quality in patients with normal tension glaucoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Optos wide-field imaging versus conventional camera imaging in Danish patients with type 2 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Evaluating an algorithm for screening intervals for diabetic retinopathy and the effect of HbA1c and hypertension

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  4. Evaluation of a screening algorithm for detection of diabetic retinopathy based on quantitation of retinal pathological elements

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

View graph of relations

PURPOSE: The late post-illumination pupillary response (PIPR 10-30s ) to blue light is reduced in glaucoma, suggesting that pupillometry can be used in clinical glaucoma evaluation. Since animal studies have indicated that common anti-glaucomatous agents affect the iris muscle, we investigated the short-term effect of the anti-glaucoma drugs on the pupillary light reflex and in particular on the PIPR10-30s.

METHODS: In this randomized, double-masked, crossover trial, pupillometry was performed before and after topical administration of latanoprost, dorzolamide, and timolol in 20 healthy subjects. Stimulus was blue (463 nm) and red light (633 nm) of 2 log (lux). Main outcome was the PIPR10-30s to blue light. Additionally, pupil size, maximal contraction, and the early post-illumination pupillary response (PIPR 0-10s ) to blue and red light were investigated. Pupil response variations between 8 a.m. and 2 p.m. were also assessed. Intraocular pressure (IOP) was measured before and 3.5 h after drug instillation.

RESULTS: We found no drug effect on the blue light PIPR10-30s or any other blue light pupil parameters. During the control day, the only significant variation over time was observed for the red light PIPR0-10s (p = 0.02). Pupillary size decreased slightly with timolol (0.1 mm, p = 0.03) and dorzolamide (0.2 mm, p < 0.001), but not with latanoprost. Timolol also reduced the maximal contraction amplitude significantly during red light (p = 0.02). Intraocular pressure was significantly reduced by all three drugs after 3.5 h (p < 0.01), while it remained unchanged during the control day (p = 0.3).

CONCLUSION: Anti-glaucoma medications did not interfere with the blue light elicited PIPR. Dorzolamide reduced pupil size, while timolol reduced both pupil size and maximal contraction to red light, but the effect was minute and not of clinical importance.

Original languageEnglish
JournalFrontiers in Neurology
Volume6
Pages (from-to)93
ISSN1664-2295
DOIs
Publication statusPublished - 2015

ID: 45977563